All-In with Chamath, Jason, Sacks & Friedberg cover image

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

00:00

Supply, Clinical Scale-Up, and Growing Use

Dave explains Lilly's large clinical program, manufacturing scale-up and estimates roughly 20 million GLP-1 users globally.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app